Jinling Pharmaceutical Company Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 2,503.732 million compared to CNY 2,534.920 million a year ago. Operating income was CNY 125.280 million compared to CNY 248.475 million a year ago. Net income was CNY 65.136 million compared to CNY 145.319 million a year ago. Basic earnings per share from continuing operations was CNY 0.1292 compared to CNY 0.2883 a year ago.